chr1-110593843-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004974.4(KCNA2):c.*9440C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 1,548,694 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00085 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0013 ( 4 hom. )
Consequence
KCNA2
NM_004974.4 3_prime_UTR
NM_004974.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.03
Publications
0 publications found
Genes affected
KCNA2 (HGNC:6220): (potassium voltage-gated channel subfamily A member 2) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, members of which allow nerve cells to efficiently repolarize following an action potential. The coding region of this gene is intronless, and the gene is clustered with genes KCNA3 and KCNA10 on chromosome 1. [provided by RefSeq, Jul 2008]
KCNA2 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 32Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 1-110593843-G-C is Benign according to our data. Variant chr1-110593843-G-C is described in ClinVar as [Benign]. Clinvar id is 1262436.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 129 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000848 AC: 129AN: 152174Hom.: 0 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
129
AN:
152174
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000604 AC: 89AN: 147276 AF XY: 0.000630 show subpopulations
GnomAD2 exomes
AF:
AC:
89
AN:
147276
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00133 AC: 1863AN: 1396520Hom.: 4 Cov.: 30 AF XY: 0.00127 AC XY: 878AN XY: 688716 show subpopulations
GnomAD4 exome
AF:
AC:
1863
AN:
1396520
Hom.:
Cov.:
30
AF XY:
AC XY:
878
AN XY:
688716
show subpopulations
African (AFR)
AF:
AC:
9
AN:
31568
American (AMR)
AF:
AC:
8
AN:
35478
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
25132
East Asian (EAS)
AF:
AC:
0
AN:
35668
South Asian (SAS)
AF:
AC:
0
AN:
78834
European-Finnish (FIN)
AF:
AC:
21
AN:
48118
Middle Eastern (MID)
AF:
AC:
0
AN:
5682
European-Non Finnish (NFE)
AF:
AC:
1767
AN:
1078118
Other (OTH)
AF:
AC:
54
AN:
57922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
82
164
247
329
411
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000848 AC: 129AN: 152174Hom.: 0 Cov.: 30 AF XY: 0.000901 AC XY: 67AN XY: 74342 show subpopulations
GnomAD4 genome
AF:
AC:
129
AN:
152174
Hom.:
Cov.:
30
AF XY:
AC XY:
67
AN XY:
74342
show subpopulations
African (AFR)
AF:
AC:
9
AN:
41432
American (AMR)
AF:
AC:
4
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5200
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
4
AN:
10618
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
107
AN:
68022
Other (OTH)
AF:
AC:
2
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 06, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.